Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Depreciation & Amortization (CF) (2016 - 2025)

Avalo Therapeutics' Depreciation & Amortization (CF) history spans 12 years, with the latest figure at $16000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 76.47% year-over-year to $16000.0; the TTM value through Dec 2025 reached $344000.0, up 103.55%, while the annual FY2025 figure was $344000.0, 103.55% up from the prior year.
  • Depreciation & Amortization (CF) reached $16000.0 in Q4 2025 per AVTX's latest filing, down from $59000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $456000.0 in Q2 2021 to a low of $16000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $124700.0, with a median of $42000.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): crashed 93.42% in 2022, then surged 306.06% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $295000.0 in 2021, then tumbled by 88.14% to $35000.0 in 2022, then grew by 22.86% to $43000.0 in 2023, then skyrocketed by 58.14% to $68000.0 in 2024, then tumbled by 76.47% to $16000.0 in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Depreciation & Amortization (CF) are $16000.0 (Q4 2025), $59000.0 (Q3 2025), and $134000.0 (Q2 2025).